With Bitcoin at $100K, Analysts Predict a Potential Correction and Altcoin Boom—5 Coins to Watch!
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
- Science
Teddy Rosenbluth
- 0
- 1 minute read
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
